Liminatus Pharma, Inc. Class A Common Stock Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
SABS
SAB Biotherapeutics, Inc. |
$3.73 | $35.65 M | -2.39 | 63 |
NNVC
NanoViricides, Inc. |
$1.33 | $23.68 M | -2.65 | 7 |
MURA
Mural Oncology plc |
$2.04 | $35.38 M | -0.29 | 116 |
MAIA
MAIA Biotechnology, Inc. |
$1.43 | $51.47 M | -1.88 | 13 |
JSPR
Jasper Therapeutics, Inc. |
$1.85 | $30.07 M | -0.32 | 64 |
GBIO
Generation Bio Co. |
$5.52 | $37.19 M | -0.58 | 115 |
EVAX
Evaxion Biotech A/S |
$6.49 | $40.99 M | -1.62 | 46 |
DYAI
Dyadic International, Inc. |
$1.00 | $36.08 M | -4.53 | 6 |
BTAI
BioXcel Therapeutics, Inc. |
$2.20 | $48.00 M | -0.24 | 37 |
ATHE
Alterity Therapeutics Limited |
$3.34 | $30.28 M | -5.57 | 10 |